Amikacin

Red

Brand Name(s):Arikayce

Indication:Treatment of non-tuberculous mycobacterial (NTM) lung infections caused by Mycobacterium avium
Complex (MAC) in adults with limited treatment options who do not have cystic fibrosis

Rationale:1,2,5

Considered:Mar-21

Review Date:Mar-26

Comments:
ARIKAYCE liposomal treatment should be initiated and managed by physicians experienced in the treatment of non-tuberculous lung disease due to Mycobacterium avium Complex.
ARIKAYCE liposomal should be used in conjunction with other antibacterial agents active against Mycobacterium avium Complex lung infections.